Loading institutional data...
Loading institutional data...
No institutional (13F) filings cover this company, so the Overview and 13F tabs are thin. Everything drawn from its SEC filings is here.
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Ranked against 22 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DIS | $191.5B | 16.2× | 10.0× | 2.0× | 3.4% | — | 13.1% | 11.3% | 8.2% | 1.6× | 1,077 |
| WMG | $15.9B | — | 18.2× | 2.4× | 4.4% | 45.8% | 5.4% | 56.4% | 7.7% | 3.3× | 69 |
| TKO | $13.1B | 79.1× | 12.1× | 2.8× | -3.1% | — | 4.1% | 5.2% | 2.6% | 2.2× | 142 |
| DKNG | $10.3B | — | — | 1.7× | 27.0% | 41.3% | 0.1% | 0.6% | 0.6% | — | 145 |
| LTH | $10.1B | 27.3× | 14.7× | 3.4× | 14.3% | 47.6% | 12.5% | 12.0% | 8.1% | 1.7× | 74 |
| CHDN | $6.4B | — | 12.4× | 2.2× | 7.0% | — | 13.1% | 37.9% | 6.2% | 5.4× | 93 |
| MTN | $5.5B | 37.5× | 11.7× | 1.9× | -4.3% | — | 5.2% | 61.3% | 4.3% | 4.1× | 92 |
| SPHR | $4.1B | 152.8× | 41.0× | 3.3× | 18.8% | — | 2.7% | 1.5% | 1.1% | 3.0× | — |
| PLNT | $4.1B | — | 12.1× | 3.1× | 12.1% | 82.6% | 16.5% | -45.4% | 11.0% | 4.2× | 80 |
| MSGE | $3.8B | 58.8× | 20.8× | 3.6× | 12.5% | — | 6.2% | 145% | 10.7% | 1.4× | 85 |
| BATRA | $3.5B | — | 66.7× | 4.8× | 10.5% | — | -3.2% | -4.4% | -1.8% | 10.3× | 53 |
| OSW | $3.1B | 43.6× | 29.2× | 3.2× | 7.4% | — | 7.5% | 13.2% | 11.4% | 0.6× | 54 |
| BRSL | $1.7B | 13.0× | — | 0.7× | -0.0% | — | 5.9% | 16.8% | 2.9% | — | — |
| GENI | $1.7B | — | — | 2.6× | 31.0% | 23.0% | -16.7% | -15.4% | -15.4% | — | 40 |
| RSI | $1.6B | 43.9× | 9.7× | 1.4× | 22.8% | 34.6% | 2.9% | 22.6% | 22.6% | -2.6× | 50 |
| PRSU | $1.5B | 69.1× | — | 3.4× | 23.4% | 92.3% | 5.0% | 3.9% | 3.3% | — | 36 |
| PRKS | $1.4B | 10.3× | 6.7× | 0.9× | -3.6% | — | 10.1% | -38.6% | 9.4% | 4.0× | 40 |
| BUUU | $1.1B | 116.8× | — | — | 8.9% | 31.0% | 12.5% | 78.7% | 55.1% | 0.3× | — |
| ACEL | $917M | 18.8× | 7.7× | 0.7× | 8.1% | — | 3.9% | 19.1% | 5.9% | 1.9× | 20 |
| FUN | $786M | — | — | 0.3× | 14.4% | 91.3% | -51.6% | -291% | -27.9% | — | 51 |
| RSVR | $632M | 73.8× | 27.6× | 3.6× | 10.7% | 64.7% | 4.7% | 2.2% | 1.0% | 11.2× | 12 |
| FBYD | $372M | 255.7× | — | 24.9× | 121% | — | 42.4% | 52.9% | 24.5% | — | 11 |
| BUKS | $324M | 14.9× | 9.6× | 3.3× | 16.7% | — | 22.4% | 26.8% | 19.7% | -0.2× | — |
Peers = companies sharing BUUU's sector (Services-Amusement & Recreation Services) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $508K dividends + $0 buybacks = $508K returned on $330K FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 3 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 55%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 3 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-30
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $6.3M 100.0% | $5.8M 100.0% | $3.5M 100.0% |
| Cost of Revenue | $4.4M 69.0% | $4.3M 74.2% | $2.8M 80.0% |
| Gross Profit | $2.0M 31.0% | $1.5M 25.8% | $708K 20.0% |
| Selling, General & Admin | $935K 14.8% | $472K 8.1% | $343K 9.7% |
| Operating Income | $1.0M 16.3% | $1.0M 17.7% | $366K 10.3% |
| Interest Expense | $16K 0.3% | $21K 0.4% | $15K 0.4% |
| Pretax Income | $1.0M 16.0% | $1.0M 17.4% | $362K 10.2% |
| Income Tax Expense | $213K 3.4% | $129K 2.2% | $31K 0.9% |
| Net Income | $793K 12.5% | $834K 14.4% | $284K 8.0% |
| Per Share | |||
| EPS (Basic) | $0.05 | $0.06 | $0.02 |
| EPS (Diluted) | $0.05 | $0.06 | $0.02 |
| Weighted Avg Shares (Basic) | 15.0M | 15.0M | 15.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~3.7% on $432K of debt.
Cash of $102K is below short-term debt of $432K — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2023, FY2024, FY2025). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
The answer is outside the range this solves over (-60% to +100%/yr), so it is reported as off the scale rather than as a rate. The price implies more growth than a decade of compounding can justify at these assumptions.
Default is 10.2% — this company's computed cost of capital, the same rate the Analysis tab discounts at.
2-stage DCF · 0.19B shares (market data) · net debt $331K
Today's price is outside this grid at every discount rate shown — the assumptions it requires lie beyond the plotted range, which is itself the finding.
mean 190.0% · volatility σ 345% · implied rate exceeded in 1/2 yrs
Central path = implied 100.0%/yr growth; shaded band = ±1σ (345%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
EOD close · as of 2026-10-30
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE 79% against ROIC 55% — 24% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 69.7% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Cost of Revenue | 80.0 | 74.2 | 69.0 |
| Gross Profit | 20.0 | 25.8 | 31.0 |
| SG&A | 9.7 | 8.1 | 14.8 |
| Operating Income | 10.3 | 17.7 | 16.3 |
| Income Tax | 0.9 | 2.2 | 3.4 |
| Net Income | 8.0 | 14.4 | 12.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BUUU: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns 47.53pts above its cost of capital, without much margin of safety.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2023 | 64.7% | 10.2% (today's — no rate published for this year) | 54.4pts |
| FY2024 | 53.2% | 10.0% | 43.2pts |
| FY2025 | 57.8% | 9.5% | 48.3pts |
| Now | 55.1% | 10.2% | 44.8pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2023 | 20.0% | 10.3% | 8.0% |
| FY2024 | 25.8% | 17.7% | 14.4% |
| FY2025 | 31.0% | 16.3% | 12.5% |
Leverage and buybacks account for 24 points of the 79% return on equity in FY2025. The business earns 55% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
The spread has been narrowing over the last three years.
Free cash flow has fallen short of reported profit in 3 of the last three years.
Capex has been below depreciation for 3 consecutive years (0.28x on average over the last 3). Spending less than the asset base is consuming flatters free cash flow now and defers the cost — though depreciation also covers amortisation of acquired intangibles, which capex is not meant to replace.
Missing from our data, so excluded from this answer: share_based_compensation.
Covers interest 45.5x even after a 30% EBITDA decline.
| EBITDA decline | Interest coverage |
|---|---|
| 0% | 64.98x |
| 5% | 61.73x |
| 10% | 58.48x |
| 15% | 55.23x |
| 20% | 51.98x |
| 25% | 48.73x |
| 30% | 45.48x |
| 35% | 42.23x |
| 40% | 38.99x |
| 45% | 35.74x |
| 50% | 32.49x |
| 55% | 29.24x |
| 60% | 25.99x |
Balance sheet at 2025-06-30. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
The maturity schedule is not part of this verdict — its filing anchor is often older than the balance sheet it sits beside, so a wall inside 24 months may not be visible here.
No growth rate within the range this model can express reaches the current price, so the requirement cannot be stated as a number.
No material counter-signal in the checked set: reverse-DCF implied growth, historical FCF CAGR, per-year FCF growth distribution, reporting-basis breaks, discount rate used, free-cash-flow basis (stock comp charged?).
Missing from our data, so excluded from this answer: implied_growth.
| Step | Amount | Running total |
|---|---|---|
| Net income | $793,420 | $793,420 |
| Share-based comp | not reported | not reported |
| Other non-cash & working capital | −$457,359 | $336,061 |
| Operating cash flow | $336,061 | $336,061 |
| Capex | −$5,699 | $330,362 |
| Free cash flow | $330,362 | $330,362 |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2024 | 64.2% | not reported | not reported |
| FY2025 | 8.9% | 49.6% | 40.7 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2023 | not reported | not reported | not reported | not reported |
| FY2024 | 55.4 days | not reported | 28.9 days | 26.6 days |
| FY2025 | 76.2 days | not reported | 26.6 days | 49.6 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2023 | not reported |
| FY2024 | 28.9 percent |
| FY2025 | 18.0 percent |
Below the line, the asset base is being consumed faster than it is replaced.
Below the line for 3 consecutive years to the latest.
Depreciation here includes amortisation of acquired intangibles — goodwill written down over time, customer lists, acquired technology. Capex does not replace those and is not meant to, so an acquisitive or asset-light company sits below 1.0 permanently and correctly. The signal is cleanest for capital-intensive businesses, where the two measure the same physical base. For that reason this informs the earnings-quality verdict but never caps it.